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Abstract
Background: Protein kinases are a well defined family of proteins, characterized by the presence of a common
kinase catalytic domain and playing a significant role in many important cellular processes, such as proliferation,
maintenance of cell shape, apoptosys. In many members of the family, additional non-kinase domains contribute
further specialization, resulting in subcellular localization, protein binding and regulation of activity, among others.
About 500 genes encode members of the kinase family in the human genome, and although many of them
represent well known genes, a larger number of genes code for proteins of more recent identification, or for
unknown proteins identified as kinase only after computational studies.
Results: A systematic in silico study performed on the human genome, led to the identification of 5 genes, on
chromosome 1, 11, 13, 15 and 16 respectively, and 1 pseudogene on chromosome X; some of these genes are
reported as kinases from NCBI but are absent in other databases, such as KinBase. Comparative analysis of 483
gene regions and subsequent computational analysis, aimed at identifying unannotated exons, indicates that a large
number of kinase may code for alternately spliced forms or be incorrectly annotated. An InterProScan automated
analysis was perfomed to study domain distribution and combination in the various families. At the same time,
other structural features were also added to the annotation process, including the putative presence of
transmembrane alpha helices, and the cystein propensity to participate into a disulfide bridge.
Conclusion: The predicted human kinome was extended by identifiying both additional genes and potential splice
variants, resulting in a varied panorama where functionality may be searched at the gene and protein level.
Structural analysis of kinase proteins domains as defined in multiple sources together with transmembrane alpha
helices and signal peptide prediction provides hints to function assignment. The results of the human kinome
analysis are collected in the KinWeb database, available for browsing and searching over the internet, where all
results from the comparative analysis and the gene structure annotation are made available, alongside the domain
information. Kinases may be searched by domain combinations and the relative genes may be viewed in a graphic
browser at various level of magnification up to gene organization on the full chromosome set.
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Eukaryotic protein kinases (ePKs) are important players in
virtually every signalling pathways involved in normal
development and disease: the transduction, amplification
and integration of many intracellular and intercellular
processes need a specific regulation made, often, by pro-
tein phosphorylation [1]. Most ePKs belong to a single
superfamily, characterized by a contiguous stretch of
approximately 250 aminoacids that constitutes the cata-
lytic domain (ePK domain) [2]. A much smaller number
of protein kinases do not share this catalytic domain with
other kinases, and are often collectively called atypical
kinases. The availability of complete sequences for human
and vertebrate genomes stimulated the computational
search of the whole sequence, in order to identify addi-
tional unknown protein kinases: Swissprot, Uniprot,
ENSEMBL [3-5] and other commonly used databases all
annotate different numbers of kinase proteins or genes.
Manning et al [6], in a systematic attempt to establish the
full set of human kinases (kinome), identified 478 ePKs
and 106 kinase pseudogenes in human genome; apart
from 40 atypical protein kinases lacking sequence similar-
ity in the ePK domain. This study was more recently
extended to cover additional species [7]. In many cases the
ability of protein kinases to regulate biological events
depends on the presence, along with the kinase domain,
of other functional domains involved in regulation, inter-
actions with other protein partners or subcellular localiza-
tion [8]. These non-catalytic domains extend the already
wide diversification of these proteins, and, at the same
time, offer a contribute to explain the high degree of this
functional diversification, suggesting alternative targets
for structural and functional analysis.
In this article we try to expand the kinase superfamily by
identifying novel protein kinases, either encoded in previ-
ously unidentified genes or generated via alternative
processing steps from the known ones, via comparative
genomics analysis. We also try to characterize the gene
products by protein sequence analysis, by means of differ-
ent tools of structure/domain prediction, including some
machine learning-based methods specifically developed
[9,10] to predict transmembrane alpha helices and
disulfide bond propensity for cysteine residues. The data
are collected in a database, where all the information from
the present study may be publicly accessed.
Results and discussion
The human kinase gene set
The exact number of protein kinases present in the human
genome is still debatable. The attempt of Manning et al. to
identify, by a combination of computational and labora-
tory findings, the full set of human kinases, showed that
the number is much less than originally expected, and
close to 500; the exact number is still subject to change,
following the refinements of the genome sequence, and
the introduction of better prediction tools. The INTER-
PRO ID IPR000719, corresponding to the domain name
"Protein kinase" [8], finds 500 human genes in
ENSEMBL, 396 in UNIPROT-Swissprot section and 1268
in the full Uniprot; a set of 452 unique entries in
ENSEMBL refer to the gene ontology entries for protein
kinase activity or more specific definitions. Kinbase, cur-
rently the most comprehensive pool of human kinases,
lists 518 kinases (478 as typical ePKs and 40 atypical
aPKs) together with 106 pseudogenes. While performing
the present analysis, Caenepeel et al. [7] published the
mouse kinome, identifying 510 mouse genes as orthologs
of the 518 human KinBase kinases; as for human kinases,
many mouse genes were not mapped or annotated in
ENSEMBL. The KinBase collection, the most accurate set
available to date, was used as the starting data set for the
present work: a PSSM obtained by PSI-BLAST analysis of
this set, using a 90 aminoacids input sequence from the
catalytic domain, was used to search for kinases in the full
human assembly. This workflow, described under "Meth-
ods" led to the identification of 5 genes on chromosome
1, 11, 13, 15, 16 respectively and 1 pseudogene on chro-
mosome X. One of them (PIK4CB) is annotated as a
kinase and four other as predicted genes in NCBI; all are
Table 1: Genomic loci identified after the described procedure
Genes Chr Start End Strand Entrez Gene 
Name
Description
1 1 148077486 148111797 Minus PIK4CB phosphatidylinositol 4-kinase catalytic beta polipeptide
2 11 120736301 120739223 Minus LOC283155 similar to bone morphogenetic protein receptor, type IA 
precursor; activin A receptor, type II-like kinase 3
3 13 51536903 51601228 Minus MGC75495 similar to NEK1 (NimA-related protein kinase 1)
4 15 34878090 34897999 Minus LOC161635 similar to casein kinase I alpha
5 16 2606123 2663452 Minus LOC440332 similar to 3-phosphoinositide dependent protein kinase-1 (hPDK1)
Pseudogenes
1 X 72527746 72529019 Minus LOC139201 mitogen-activated protein kinase kinase 4 pseudogenePage 2 of 11
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CST distributionFigure 1
CST distribution. (a) Full set of CSTs found in the selected genomic regions (See Methods), grouped according to ENSEMBL 
gene and exon annotation. Exonic CSTs are indicated as In exon when completely included in one exon, Span 5' or Span 3' 
when overlapping the 5' or 3' end of one exon, Span 5'-3' when CST contains one exon, Multi exon or Multi Transcript when a 
larger CST covers more than one exon of one or more transcripts. (b) CSTs contained within the analysed kinase genes: 20% 
of the CSTs, initially annotated as intronic, are indicated as "exon-like" because positive to one or more of the tests described 
under methods. (c) Exon-like CSTs within the analysed kinase genes, positive to one, two, three and four of the used test cri-
teria (see methods). (d) Number of kinase genes containing at least one exon-like CST positive to two, three or four tests.
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BMC Bioinformatics 2005, 6:S20absent from the Kinbase database (Table 1). Moreover, 7
pseudogenes and the 'KIS' kinase gene presented different
chromosomic localization from the KinBase annotation.
Kinase gene analysis
Starting from the new pool of kinase genes, including the
518 from Manning and 5 new ones from our analysis, we
proceeded to a comparative analysis of man and mouse
orthologous kinase genes, aimed to the identification of
small genomic conserved sequence tags (CSTs). As func-
tional sequences tend to evolve at a slower rate than neu-
tral sequences, information about conserved regions in
these genes, obtained from alignment of DNA sequences
from different species, such as human and mouse, pro-
vides an useful opportunity to amplify the knowledge
about coding sequences, alternatively spliced exons or
about other regulatory elements. The analysis was per-
formed according to a tool, previously developed in our
lab for identification of CSTs in disease genes [11]. Briefly,
given a list of target genes, human genomic regions span-
ning the selected transcripts are identified and compared
to their mouse counterparts as defined according to
ENSEMBL orthologous definitions; when the target genes
are very close, they are included in the same genomic
region. Stretches longer than 100 bp and sharing a mini-
mum of 70% identity, are selected as CSTs and assigned to
the nearest gene. As ENSEMBL gene codes were not avail-
able for all human kinases, gene codes for the kinase gene
set were determined according to their gene name or con-
tig position and manually verified. From the initial set,
483 could be analyzed: sequences from man and mouse,
corresponding to genomic regions spanning the selected
kinase transcripts, were extracted from ENSEMBL, masked
for repeats and compared for the identification of CSTs.
The comparison led to the identification of about 35000
human (and mouse) CSTs, which together cover about
8% of the selected human regions. Kinase CSTs are mostly
unique and half of them correspond to the expected exons
for genes contained in the analyzed regions. A summary
of the CSTs grouped by gene type is reported in Fig. 1a.
The CST collection underwent several annotation steps
involving:
• basic features concerning sequence content and similar-
ity with orthologous counterpart, such as GC%; number
of gaps, length, sequence identity, polarity.;
• genomic localization, according to ENSEMBL data and
concerning chromosomal coordinates, relationship with
the target and the closest gene (i.e. distances from tran-
scription and coding start, transcription and coding end,
according to gene orientation), sequence gene type (i.e.
intergenic, intronic, exonic), number of known SNPs;
• predicted functional features, concerning the identifica-
tion of motifs and putative signals, such as transcription
factor binding sites, exonic splicing enhancers (ESE), RNA
secondary structures, palindromes and tandem repeats.
Many CTSs reported in Fig. 1a as intergenic or intronic
(i.e. non-exonic), could of course represent additional,
previously unidentified exons, either constitutive or alter-
natively spliced, and their identification would lead to
further expansion of the available kinome. Several com-
putational tests were therefore directed to determine the
coding potential, including identification of the long
open reading frames, calculation of codon frequency and
periodicity, statistics on synonymous codon usage, coinci-
dence with exons and suboptimal exons of genes pre-
dicted by running GENSCAN on the selected human
genomic regions. In addition human and mouse EST col-
lections were scanned by BLAST for similarity to human
and mouse CSTs, and different genomic annotations were
compared to highlight differences between human and
mouse annotations, such as human CSTs annotated as
intergenic or intronic with mouse counterpart annotated
as exonic. The last four tests, i.e. coincidence with GENS-
CAN exons, matches with human or mouse EST and
annotation as exons in mouse are, alone or in combina-
tion, particularly convenient criteria to assess the exon
potential: about a third of the CSTs initially marked as
intronic or intergenic were positive to at least one of the
described criteria and should be considered as "exon-like"
(Fig. 1b). Concomitant positivity to more than one crite-
ria is often observed and allows to rank sequences in
classes of higher potential to be unannotated constitutive
or alternatively spliced exons (Fig. 1c). The number of
kinase genes containing such CSTs is large: results are
likely to represent unannotated constitutive exons or to
code for alternatively spliced isoforms: about half of the
genes contain at least one region positive to two or more
of the four criteria mentioned above (Fig. 1d).
Manual analysis of some exon-like CSTs, identified with
the above described procedure, revealed potential kinase
isoforms that could be validated against information cur-
rently available in literature. The human gene encoding
fibroblast growth factor receptor 1 (FGFR1) includes an
unannotated exon which, if inserted into the mRNA, pro-
duces a FGFR1-IIIb form, not currently annotated in the
used databases. This exon is consistent with the common
gene organization seen both in man and mouse in the
genes coding for other FGFR isoforms, which underlies
the mechanisms for generating receptors differing in their
third immunoglobulin domain: three different exons
(IIIa, IIIb and IIIc) encode possible alternatives within the
third Ig-like domain at the N-terminal end of the mole-
cule (Fig. 2a). A literature search provided experimental
evidence supporting the existence of FGFR1-IIIa and IIIcPage 4 of 11
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BMC Bioinformatics 2005, 6:S20transcript variants both in human and mouse, and a
cDNA containing the IIIb exon in mouse. A recombinat
protein containing the human IIIb sequence is active;
RNAse protection and PCR experiments confirm the exist-
ence of the m-RNA encoding the FGFR1-IIIb in mouse
and human brain [12-14].
Two CSTs identified in CDKL2 (Cycline-dependent
kinase-like 2), a member of the cdc2-related serine/threo-
nine kinase subfamily, contain putative exons inserted
into the 3' end of the coding region (fig. 2b). The gener-
ated protein differs from CDKL2 in its C-terminal domain
by increasing the length of a random coil region located at
the carboxy-end of the protein, a region in which previous
analysis of mouse cDNA clones already revealed multiple
variants generated by alternative splicing events. These
exons are not described in the numerous species where
the protein has been reported, with the only exception of
rabbit, where a similar sequence from deep cerebellar
nuclei is described as the only form available [15]. Despite
their similarity with cdc2, most of the members of this
family show roles other than cell cycle regulation and are
expressed in terminally differentiated cells of the nervous
system. Consistently, a human EST ending in a poliA+ tail
confirms its inclusion in human brain RNA and provides
evidence for a brain specific form of the protein.
Similarly, VRK1 (vaccinia-related kinase 1) shows an extra
exon contained within CST, which is suggestive of an
alternative splicing event localized at the 3' end of the
VRK1 gene, affecting the low complexity domain at the C-
terminus of the protein (Fig. 2c). The protein, identified
from a new group of human serine/threonine kinases,
known to prevent p53 ubiquitinization via phosphoryla-
tion in thr-18 [16,17], only has one isoform according to
the SWISSPROT protein database, while five alternative
products are reported as predicted for the murine one.
Structure-function relationship in kinase proteins
The human kinase genes, in addition to the catalytic
domain, contain several other domains involved in vari-
ous regulation processes. In order to evaluate the domain
distribution in all human kinases, an automated proce-
dure was developed based on an INTERPRO-Scan analysis
of the protein kinase sequences. The procedure led to the
identification of 20 families, 91 different domains, 12
Some kinase genes containing extra exonsFigure 2
Some kinase genes containing extra exons. (a) FGFR1 gene. (b) CDKL2 gene. (c) VRK1 gene. Putative new exons derived 
from CST analysis are reported are marked by a dot. Splicing patterns are indicated by continuous (known) and dashed (pre-
dicted) lines. Exons encoding kinase, transmembrane and Ig-like domains are indicated; white boxes represent untranslated 
RNA sequence, a star marks the leader peptide of FGFR1.
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Comprehensive analysis of protein kinase schemaFigure 3
Comprehensive analysis of protein kinase genes. (a)The pipeline used for the annotation of the kinase genes is repre-
sented in this schema, information deriving from the gene annotations are recorded into the relational database KinWeb. (b) 
Count of domains identified within the kinase gene pool.(c)Prediction of structure features in kinase protein sequences.
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Structural features predicted in kinases
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BMC Bioinformatics 2005, 6:S20repeats, 1 binding site (Fig. 3a). The domains found are
reported in Fig. 3b, sorted by frequency; domains appear-
ing less than 6 times are not reported in figure. A majority
of the human protein kinases contains at least one
domain other than the catalytic kinase domain. Many
domains are useful to function assignment: 60 kinases
The KinWeb databaseFigure 4
The KinWeb database. The interface provides access to the data in various ways: (a) The KinWeb home page. A query 
form allows to search by gene name, classification group or domain. (b) The genome browser, allowing view and selection of 
the genomic regions where kinase genes are located. (c) The multi-domain search page. Here kinases can be searched accord-
ing to a combination of domains. (d) Example of results from multi-domain search in (c). For each protein, all domains pre-
dicted by InterProScan are graphically represented.
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BMC Bioinformatics 2005, 6:S20present domains that interact with nucleic acids, 53
present domains linked to lipid signalling, 37 kinases
include domains related to GTPase signalling, 12 kinases
present domains involved in calcium signalling, 8 kinases
present domains able to target the protein to the cytoskel-
eton. Some domains are present in multiple copies: 2 to 8
Fibronectin type III domains are present in TIE, AXL, ROS,
InsR and related kinases, located before the catalytic
domain. Src Homology 2 (SH2) and Src Homology 3
(SH3) are adaptor domains involved in the recruitment of
proteins to their specific target and are frequently found in
kinases of the TK family: 19 kinases contain both
domains, while 10 kinases contain the sole SH2 domain
and 8 the sole SH3 domain. In kinases such as TEC, SRC,
CSK and ABL, that contain both the SH3 and SH2
domains, the peptide that connects SH2 and catalytic
Annotations available for each kinase geneFigure 5
Annotations available for each kinase gene. (a) The "Gene Report" page shows gene annotations extracted from public 
databases, the results of predictions for transmembrane domains and Cys disulfide bonding state and links the identified CSTs 
to the graphical representation of the gene. (b) Graphical representation of the gene and related transcripts and CSTs. Details 
are shown for the CTS under the mouse pointer. CSTs are color-coded based on degree of conservation. (c) The CST details 
page, where full details of the selected CST are shown, including the results of BLAST searches.
(a)
(b)
(c)Page 8 of 11
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BMC Bioinformatics 2005, 6:S20domain tends to maintain similar lengths, on average 20
amino-acids long. The large number and diversity of non-
kinase domains, contained within protein kinases, is
directly related to the high degree of functional diversifi-
cation, which greatly depends on their ability to interact
with a large number of other cellular proteins, mainly via
additional subunits or domains. The concomitant pres-
ence of additional, non-catalytic, domains may thus lead
to the understanding of possible interacting partners and
intracellular pathways recruited, unltimately hinting to a
specific cell function.
Further information in our data mining system comes
from an exhaustive prediction of transmembrane
domains and other structural features. This information
allows to better understand the connection between struc-
ture and function of known proteins, but also permits to
express hypothesis about the role and the subcellular
localization of novel proteins. Filtering of the kinase
sequence set with machine-learning based methods, spe-
cifically suited to predict signal peptides, transmembrane
protein domains of the alpha helical type and propensity
of cysteine residues to form disulfide bridges, allowed the
annotation on predictive basis of these characteristics. The
results are shown in Fig. 3c. We found that 13.5% of the
kinase sequences are endowed with signal peptides, sug-
gesting that these proteins may be secreted via the SEC-
dependent secretory pathway; 40.9% are endowed with at
least one transmembrane domain different from the sig-
nal peptide, a number substantially higher than the
18.4% annotated as containing a Tm domain in the Swiss-
prot database; 15% of the kinases are endowed with at
least one disulfide bridge.
KinWeb database
All the results produced by the analysis have been inte-
grated with the information about kinase genes derived
from public databanks into a new database, KinWeb,
which is available as a public access site at the following
addresses: http://www.itb.cnr.it/kinweb and http://kin
web.ceinge.unina.it. The human kinome may be accessed
through a graphic genome browser and investigated at the
genomic level, starting from kinase gene locations, and,
progressively adding detail, at the level of gene structure
and corresponding CSTs. Kinase genes may be searched
on the basis of structural features, such as domain combi-
nations, and various annotations, i.e. gene name or kinase
group (Fig. 4). It is also possible to use BLAST for similar-
ity searches between a given sequence and kinase proteins
or cDNAs. A sequence may also be compared through
HMMER with the full set of available catalitic domains.
The information stored for each kinase gene consists of
annotations automatically extracted from public data-
banks or literature such as:
• alternative names as defined in the HUGO database;
• family classification according to Manning;
• transcript variants and genomic contig names and coor-
dinates from RefSeq;
• functional annotations from Gene-Entrez;
• information about transcripts, exons and genomic coor-
dinates from Ensembl;
• direct links to RefSeq, Gene-Entrez, OMIM, Ensembl
and SwissProt databases, together with the Kinbase pro-
tein and mRNA sequences.
These annotations are stored alongside the results from
the present analysis on kinase genes and proteins. The
available data include:
• type and position of detected domains;
• predictions for secondary structure, transmembrane
domains and cystein propensity to form disulfur bridges;
• mouse orthologous kinase genes;
• CSTs common to human and mouse;
• all CST annotations.
The CST elements and their complete annotations are
associated with the corresponding gene, but may also be
seen, with the help of a graphic browser, in their chromo-
somal context and in relation to the exons of the gene
transcripts; color code is used to label CSTs according to
the various annotations, including the number and type
of BLAST matches found (Fig. 5). A link leads from each
human kinase gene to the orthologous mouse gene, where
information on structure and CSTs, also stored within the
database and accessible through the graphic browser, are
available. Altoghether the data provide an exaustive anal-
ysis of various aspects of gene and protein features for
each kinase, integrating data from literature and other
DBs with information about gene organization, sequence
conservation and protein structural predictions, obtained
within the present analysis.
Conclusion
The predicted human kinome was extended by identifying
kinase genes through a custom built pipeline and by iden-
tifying a large number of non-exonic, apparently non-cod-
ing, highly conserved sequences through comparative
analysis. Some of these conserved sequences were anno-
tated as exon-like, and may be responsible for additionalPage 9 of 11
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may play different roles, for example contribute to regula-
tion of gene expression. Domain analysis and prediction
of structural features provide further information, result-
ing in a varied panorama where functionality may be
searched at the gene or protein level. All results from the
comparative analysis and the gene structure annotation
are made available alongside the domain information in
the KinWeb database, made available for browsing and
searching over the internet and where it is possible to
search for kinases by domain combinations and to visual-
ize the relative genes, including annotation of conserved
sequences. A graphic browser is used to view kinase genes
at various levels of magnification, from single exons up to
gene organization on the full chromosome set.
Methods
Kinase gene identification
A contiguous stretch of approximately 90 aminoacids,
containing the well known "DxxxxN, DFG, APE, DxxxxG"
motif, was extracted from an arbitrarly choosen kinase,
ABL, and used as input to a three-iteration PSI-BLAST
search of a query database containing the whole kinase
dataset identified by Manning and coworkers [6]. The
resulting Position Specific Score Matrix (PSSM) was used
as a query sequence to perform tBLASTn agaist all human
chromosome sequences, available from NCBI, release
April 14 2003; human sequences had been previously
masked to remove sequences coding for kinase genes con-
tained in the starting set. Sequence regions matching the
PSSM were extracted and extended 200 kb upstream and
downstream for full length gene prediction on the result-
ing genomic region by GenomeScan http://
genes.mit.edu/. This software allows prediction of genes
on the basis of an input protein expected to be similar to
the gene product encoded in the DNA sequence. We
found such proteins by doing a BLASTX comparison of
our sequences to all known proteins.
Kinase domain identification
For each human hit, all the features (gene name, alterna-
tive names, classification) were stored into a table of a
relational database, along with protein, mRNA and kinase
catalytic domain sequences. Pseudogenes were manually
curated and inserted into a distinct relational database. All
putative kinases were then analyzed by using the InterPro-
Scan for the complete domain annotation. InterProScan
[4] is freely available under the GNU licence agreement
from the EBI's ftp server ftp://ftp.ebi.ac.uk/pub/data
bases/interpro/iprscan/. The output generated in XML for-
mat, is parsed by a Perl script in order to extract all the
annotations and recorded into a MySQL relational data-
base which can be consulted through interfaces written in
PHP, and can be visualized with common browsers over
the internet.
CST identification
Human/mouse orthologous regions corresponding to
kinase genes were taken from ENSEMBL annotation,
when available, or by manual identification based on
sequence conservation. The limits of the genomic
sequences were set between 20 kb and 250 kb depending
on the distance of the closest known gene. Species-specific
repeats were masked and BLASTZ was used for compari-
son. The final set of about 33000 CSTs was finally selected
according to the parameters described in the "Results" sec-
tion.
CST annotation
Annotation of human and murine CSTs was carried out
through a pipeline, formed of several independent mod-
ules. The pipeline is based on PHP scripts and includes:
classification of CST type according to Ensembl gene def-
initions, coding capability according to Ensembl exon def-
initions, GC content, distances from analysed and closest
genes and coding regions.
A number of programs, were run on the whole CST set to
annotate specific features: equiktandem and palindrome
were used to identify direct and inverted repeats; marscan
to annotate MAR sites; tcode, syco and getorf to assess
coding potential; Genesplicer http://cbcb.umd.edu/soft
ware/GeneSplicer/ to detect splice sites; GENESCAN was
used for ab initio transcripts and suboptimal exons predic-
tion. equiktandem, palindrome, marscan, tcode, syco and
getorf are EMBOSS applications http://emboss.source
forge.net.
BLAST searches
BLAST was run on all CSTs to annotate matches within the
human and mouse genomes: matches showing score
higher than 50 or E-value better than 10-5 were kept as
annotations in the DB. Similarly results of BLAST runs of
all CSTs against human and mouse EST libraries having E-
value better than 10-20, length and identity higher than 30
and 90 respectively, have been annotated.
Exon like definition
The CSTs are annotated as exon-like when one or more of
the following conditions is verified:
- mouse counterpart is annotated as exonic
- CST matches with GENSCAN exons or suboptimal exons
- CST matches with one or more human EST
- Mouse counterpart matches with one or more rodent
ESTPage 10 of 11
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CSTs are fed to an SQL-database. The pipeline is able to
manage CST import together with automatic annotation.
The WEB interface consists of PHP scripts, which query
the database and dynamically generate the result pages.
The graphic visualization tool has been developed in PHP
and is based on the GD graphics library http://
www.boutell.com/gd/.
Signal peptide prediction
The entire set of proteins was filtered with SPEPlip, a neu-
ral network-based method for predicting the presence of a
signal peptide, trained and tested on a set of experimen-
tally derived signal peptides from eukaryotes and prokary-
otes. SPEPlip identifies the presence of sorting signals and
predicts their cleavage sites. The accuracy is 97%. It can be
accessed through the web page at http://gpcr.bio
comp.unibo.it/
All-alpha membrane proteins prediction
All-alpha membrane proteins constitute a functionally
relevant subset of the whole proteome. Their content
ranges from about 10 to 30% of the cell proteins, based on
sequence comparison and specific predictive methods.
ENSEMBLE is an ensemble of methods, containing a cas-
cade-neural network (NN) and two different hidden
Markov models (HMM). It was trained and tested in cross
validation on 59 well resolved membrane proteins, avail-
able when the method was implemented. ENSEMBLE
scores with a per-protein accuracy of 90% for topography
and 71% for topology. When tested on a low resolution
set of 151 proteins, with no homology with the 59 pro-
teins, the per-protein accuracy of ENSEMBLE is 76% for
topography and 68% for topology.
Disulfide bond prediction
The propensity of disulfide-bonded cysteines has been
predicted with a Hidden Neural Network-based method
starting from the residue sequence of the protein chain.
The method scores as high as 89% and 86% per cysteine
residue and per protein, respectively, and in this it is supe-
rior to other predictors of the same category.
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